---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-229657"
form_type: "8-K"
ticker: "DFTX"
cik: "0001813814"
company_name: "Definium Therapeutics, Inc."
filed_at: "2026-05-19T11:30:21+00:00"
generated_at: "2026-05-19T11:36:34.557863+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Definium Therapeutics posts updated corporate presentation; no specifics disclosed

## Summary
- Updated corporate presentation posted to company website on May 19, 2026.
- No financial results, guidance changes, or pipeline updates can be extracted from the filed exhibit.
- Confidence is low because the presentation content beyond the cover page was not provided.
- Ticker DFTX; event is routine with no directional signal.

## SEC filing metadata
- accession: 0001193125-26-229657
- form_type: 8-K
- ticker: DFTX
- cik: 0001813814
- company_name: Definium Therapeutics, Inc.
- filed_at: 2026-05-19T11:30:21+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1813814/000119312526229657/0001193125-26-229657-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1813814/000119312526229657/dftx-20260519.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-229657
- JSON: https://secwatch.observer/filing/0001193125-26-229657.json
- Plain text: https://secwatch.observer/filing/0001193125-26-229657.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.